| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/25/2005 | EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
| 05/25/2005 | EP1056724B1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 05/25/2005 | EP1054993B1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 05/25/2005 | EP1047701B1 Mitochondrially targeted antioxidants |
| 05/25/2005 | EP1039911B1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS |
| 05/25/2005 | EP0907370B1 Hla-a2.1 binding peptides and their uses |
| 05/25/2005 | EP0904274B1 Farnesyl transferase inhibitors |
| 05/25/2005 | EP0836613B1 Water-soluble adenosine kinase inhibitors |
| 05/25/2005 | EP0814796B1 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer |
| 05/25/2005 | CN1620510A Cytokine protein family |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620464A Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors |
| 05/25/2005 | CN1620459A 稠合双环嘧啶衍生物 Fused bicyclic pyrimidine derivative |
| 05/25/2005 | CN1620458A 噻吩并嘧啶 Thienopyrimidine |
| 05/25/2005 | CN1620457A Tetracyclic heterocompounds as estrogen receptor modulators |
| 05/25/2005 | CN1620454A Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 05/25/2005 | CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 05/25/2005 | CN1620451A Benzhydryl derivatives |
| 05/25/2005 | CN1620447A Isochroman compounds for treatment of cns disorders |
| 05/25/2005 | CN1620439A Pancreatic lipase inhibitor compounds, their synthesis and use |
| 05/25/2005 | CN1620438A 5, 6-diaryl-pyrazine-2-amide derivatives as CBI antagonists |
| 05/25/2005 | CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors |
| 05/25/2005 | CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 05/25/2005 | CN1620429A Derivatives of alpha-phenylthiocarboxylic and g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPAR alpha activation |
| 05/25/2005 | CN1620423A Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR) |
| 05/25/2005 | CN1620422A Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR) |
| 05/25/2005 | CN1620421A Substituted alkyl diamine |
| 05/25/2005 | CN1620419A 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 05/25/2005 | CN1620414A 维生素d类似物 Vitamin d analogues |
| 05/25/2005 | CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 05/25/2005 | CN1620307A Anti-HIV agent |
| 05/25/2005 | CN1620305A Method of inducing apoptosis and compositions therefor |
| 05/25/2005 | CN1620304A Prevention and treatment of oxidative stress disorders by glutathione and phase IIdetoxification enzymes |
| 05/25/2005 | CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 05/25/2005 | CN1620296A Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 05/25/2005 | CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 05/25/2005 | CN1620292A Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors |
| 05/25/2005 | CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors |
| 05/25/2005 | CN1620290A Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 05/25/2005 | CN1620288A Pharmaceutical use of COX-2 inhibitors in angiogenesis-mediated ocular disorders |
| 05/25/2005 | CN1620286A Compounds for blocking androgen receptors |
| 05/25/2005 | CN1620257A Matrix-forming composition containing pectin |
| 05/25/2005 | CN1618969A Mammalian sytokine-like polypeptide-10 |
| 05/25/2005 | CN1618790A New Optical active derivative of flavo acidamide, its preparation method and its medicinal composition and use |
| 05/25/2005 | CN1618789A Macrocyclic peptides active against the hepatitis C virus |
| 05/25/2005 | CN1618462A Compositions of SOD and vetetative medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618461A Composition of nano-SOD and vegetative medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618460A Composition of SOD and animal medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618435A Oral liquor for promoting-blood circulation and removing blood stasis contg. Radix astragali and ginseng |
| 05/25/2005 | CN1618432A Complement inhibitor |
| 05/25/2005 | CN1203184C Process for preparation of pseudomonic acid A antibiotic by microbiological method |
| 05/25/2005 | CN1203091C TGF (b) 1 inhibitor peptides |
| 05/25/2005 | CN1203090C Cyclic bonding inhibitor |
| 05/25/2005 | CN1203087C Factor VIIa inhibitors |
| 05/25/2005 | CN1203070C Thrombin receptor antagonists |
| 05/25/2005 | CN1203069C Substituted piperidines, medicaments containing these compounds, and methods for production thereof |
| 05/25/2005 | CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors |
| 05/25/2005 | CN1203060C Pyridine derivatives, its composition and use |
| 05/25/2005 | CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 05/25/2005 | CN1202865C Synergistic combination |
| 05/25/2005 | CN1202852C Traditional Chinese medicine for treating wind-cold type of common cold and preparation process thereof |
| 05/25/2005 | CN1202850C Capsule possessing antisenescent, skin restoring and spot dispelling effect and method for making the same |
| 05/25/2005 | CN1202828C Use of diphosphonic acid in preparing medicine for treatment of vasculogenesis |
| 05/25/2005 | CN1202823C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 05/25/2005 | CN1202821C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (MIDDM) attack |
| 05/25/2005 | CN1202803C Mixture for oxidation tinting of keratin fibres containing laccase and tinting method using said mixture |
| 05/25/2005 | CN1202735C Pet for copmosition |
| 05/24/2005 | US6897319 Therapeutic drugs for treating central nervous system disorders |
| 05/24/2005 | US6897310 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction |
| 05/24/2005 | US6897293 A DNA sequence encoding a gax protein or portion, which inhibits vascular smooth muscle cell proliferation, useful in the treatment of blood vessel diseases |
| 05/24/2005 | US6897238 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris |
| 05/24/2005 | US6897237 MMP-12 inhibitors |
| 05/24/2005 | US6897235 Compositions useful for the treatment of pathologies responding to the activation of PPAR-γ receptor |
| 05/24/2005 | US6897233 Enzyme inhibitors, a 2-oxopyrrolidin-3-yl-N-hydroxyacetamide derivatives; bactericides |
| 05/24/2005 | US6897232 Activate soluble guanylate cyclase; for use treating cardiovascular disorders, erectile dysfunction, diabetes, and cirrhosis of the liver, kidney disorders, and learning disability |
| 05/24/2005 | US6897229 Use of PDE4 inhibitor N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide, salts or its N-oxide with PDE3 inhibitor for treatment of obstructions of bronchi |
| 05/24/2005 | US6897227 Prodrugs of proton pump inhibitors |
| 05/24/2005 | US6897226 NK-1 receptor active amine oxide prodrugs |
| 05/24/2005 | US6897221 Urea substituted imidazoquinolines |
| 05/24/2005 | US6897216 Adenosine A2a receptor antagonists |
| 05/24/2005 | US6897212 Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones |
| 05/24/2005 | US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 05/24/2005 | US6897210 Anticancer agents; antiarthritic agents |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | US6897206 Combinations for the treatment of inflammatory disorders |
| 05/24/2005 | US6897054 For controlling in vitro cell proliferation; genetic engineering |
| 05/24/2005 | US6897034 Antitumor agents; drug immobilized to oligopeptide; complexing; testing, calibration of complex to see if capable of being split enzyme; drug design |
| 05/24/2005 | US6896909 Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders |
| 05/24/2005 | US6896904 Multilayer crosslinking porous structure; prosthetic bones, drug delivery |
| 05/24/2005 | US6896891 Non-systemic control of parasites |
| 05/24/2005 | US6896880 Interleukins; osteoporosis therapy |
| 05/24/2005 | CA2211177C Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates |
| 05/24/2005 | CA2170243C Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 05/24/2005 | CA2151476C Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 05/24/2005 | CA2109259C Prodrugs, their preparation and use as pharmaceuticals |
| 05/19/2005 | WO2005044290A1 Glucose absorption inhibitor and process for producing the same |
| 05/19/2005 | WO2005044283A1 Allergic constitution ameliorator |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | WO2004078145B1 Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis |
| 05/19/2005 | WO2004016726A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |